Moneylife has already pointed out how State Bank of India’s (SBI) ‘zero processing fees’ offer is a sham (it merely harasses customers by transferring the cost and burden of getting various documents verified on to them) and its teaser interest rates will rise soon enough. For many months now, bankers have been agitated at SBI’s predatory action, especially since it has happened so soon after...
A few funds held large cash levels in November. Was it a prudent move?
One of the tenets of fund investing is to remain fully invested at all times. Since it would go against the ‘remain fully invested’ philosophy, funds have not developed the expertise to time the market. Of course, this does not mean that they don’t try. Funds sometimes try to increase cash levels at what they perceive as...
Surya Pharma is on a growth path
We have been impressed by small pharma companies like Aarti Drugs and Ankur Drugs and their performance has justified our recommendation. Here is one more pharma stock to look at. Surya Pharmaceutical manufactures and markets active pharmaceutical ingredients (APIs) or bulk drugs, drug formulations and bulk intermediates. It has manufacturing plants in...
